A spokeswoman for Sen. Charles Grassley says documents submitted by GlaxoSmithKline on its drug Paxil have, at first glance, not alleviated the lawmaker’s suspicions that GSK knew about increased suicide risks associated with the antidepressant years before it sent a 2006 warning letter to physicians.
“Our concerns have not changed,” says spokeswoman Jill Kozeny.
The lawmaker received a tall stack of papers from GSK the day after his deadline for the company to submit documents on Paxil. Kozeny says Grassley’s staff is going through the documents this week and declined to comment on the next steps Grassley might be.
Read more about Grassley and GlaxoSmithKline’s missing documents here and here.
February 22, 2008 at 9:37 pm
Time for the GSK guys to start practicing their “I’m sorry” faces. (:
February 22, 2008 at 10:05 pm
Interesting..
I would have thought Glaxo shredded the evidence by now… (surely that would be more their style?)
I wonder what information these documents contain?…
February 25, 2008 at 8:29 am
I read a little of Dr. Glenmullen’s report and it is the validation I’ve been looking for. At the end of it he lists studies which have been done on akathisia and anti-depressant-induced suicidality. I hope an MP is trying to get those missing pages, too.